Professionals 92 results
Capabilities 28 results
Industry
Industry
Practice Area
Experience 3 results
Experience
|December 20, 2021
ACON Investments' Acquisition of Vitalis Group
Experience
|July 17, 2020
Defended Generic Drug Manufacturer in Trade Dress Infringement Case
Experience
|March 29, 2019
Rare Noninfringement Jury Verdict for Teva N.A. in Patent Infringement Case for Suboxone® Tablets
Insights & News 326 results
Speaking Engagement
|April 25, 2024
Ivan Poullaos Discusses Jury Trial Preparedness in ANDA Cases at Paragraph IV Disputes Conference
Competition Corner
|April 24, 2024
|3 Min Read
U.S. Antitrust Agencies Seek Tips on Anticompetitive Conduct in the Health Care Space
Health care companies and stakeholders should be prepared for an uptick in antitrust complaints and investigations in the short term, driven by the launch of HealthyCompetition.gov. Despite the anticipated short-term impact, the long-term impact remains uncertain and depends on the sustained engagement and use of the tipline by the public.
Government Program Fraud, False Claims Act & Qui Tam Litigation Playbook
|April 17, 2024
|9 Min Read
E.D. Virginia Endorses Broad Interpretation of Anti-Kickback Statute
The U.S. District Court for the Eastern District of Virginia is the latest court to weigh in on the continuing debate surrounding the scope of the Federal Anti-Kickback Statute (AKS) as it applies to patient assistance programs (PAPs). In a lengthy opinion issued in January 2024, the court endorsed the broad interpretation advanced by the government, expressing little sympathy for the legal or policy arguments advanced by the plaintiffs, a coalition of pharmaceutical manufacturers. The coalition has indicated it will appeal the case to the Fourth Circuit.
Other Results 29 results
Law Glossary
Law Glossary
What Is the Approval Process for Generic Drugs?
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?